End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
285.9 ZAR | -0.30% | +1.20% | -12.22% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Over the past four months, analysts' average price target has been revised upwards significantly.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- With a 2024 P/E ratio at 24.07 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Drug Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-12.22% | 3.58B | B | ||
-32.59% | 15.18B | B- | ||
-31.97% | 10.1B | B | ||
+9.54% | 6.12B | C | ||
-11.41% | 5.97B | C+ | ||
-30.42% | 5.65B | B | ||
-0.88% | 4.71B | D- | ||
+51.58% | 4.26B | - | C | |
-16.75% | 3.26B | C- | ||
-6.93% | 3.07B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CLS Stock
- Ratings Clicks Group Limited